Chemical Structure : DF-003
Catalog No.: PC-25504Not For Human Use, Lab Use Only.
DF-003 (DF003) is a potent, selective and ATP-competitive alpha-kinase 1 (ALPK1) inhibitor with IC50 of 1.5 nM and 16 nM for human ALPK1 and ROSAH disease-causing mutant ALPK1[T237M] respectively.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
DF-003 (DF003) is a potent, selective and ATP-competitive alpha-kinase 1 (ALPK1) inhibitor with IC50 of 1.5 nM and 16 nM for human ALPK1 and ROSAH disease-causing mutant ALPK1[T237M] respectively.
DF-003 exhibits good selectivity for ALPK1 against a panel of 394 human kinases, >860-fold selectivity over the closest kinase.
DF-003 blocks induction of TIFAsome formation and chemokine/cytokine production by the ALPK1 agonist DF-006 (Cat. PC-47007).
DF-003 inhibits the kinase activity of ALPK1[T237M] and blocks NF-κB target gene expression induced by ALPK1[T237M], DF-003 suppresses (IC50 = 125 nM) the enhanced secretion of CXCL8 from HEK-293 cells overexpressing ALPK1[T237M].
DF-003 (3 mg/kg) inhibits retinal microglia and astrocyte activity in ROSAH mice.
DF-003 suppresses pro-inflammatory gene upregulation in the retina, optic nerve, and brain cortex of ROSAH model mice.
M.Wt | 486.97 | |
Formula | C24H21ClF2N4OS | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Fan J, et al. Discovery of a selective alpha-kinase 1 inhibitor for the rare genetic disease ROSAH syndrome. Nat Commun. 2025 Sep 9;16(1):8251.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright